Biosynthetic Technologies is a series a startup based in United States. 1 investor tracked.
Based in the United States, Biosynthetic Technologies is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Biosynthetic Technologies manufactures a new class of bio-based synthetic compounds called Estolides that are derived from sustainable plant oils.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.